Skip to Main Content
CKG
Home
Home
Home
TKG
Author details
Breadcrumb
Author Details
Full Name
Reid F Thompson
Affiliation
Oregon Health and Sciences University
ORCID
Career Start Year
2002
Papers
61
H Index
23
Expertise
CM4AI Collaborator
PMID
Paper Title
Journal Title
Published Year
36793398
Stress-testing pelvic autosegmentation algorithms using anatomical edge cases.
Phys Imaging Radiat Oncol
2023
36874953
recountmethylation enables flexible analysis of public blood DNA methylation array data.
Bioinform Adv
2023
34491610
Urine DNA for monitoring chemoradiotherapy response in muscle-invasive bladder cancer: a pilot study.
BJU Int
2022
35468987
Plasma cell-free RNA profiling distinguishes cancers from pre-malignant conditions in solid and hematologic malignancies.
NPJ Precis Oncol
2022
36711064
Head and Neck Radiation Therapy Patterns of Practice Variability Identified as a Challenge to Real-World Big Data: Results From the Learning from Analysis of Multicentre Big Data Aggregation (LAMBDA) Consortium.
Adv Radiat Oncol
2022
36369064
Retained introns in long RNA-seq reads are not reliably detected in sample-matched short reads.
Genome Biol
2022
35322234
Androgen receptor activity in T cells limits checkpoint blockade efficacy.
Nature
2022
32544635
National Cancer Institute Workshop on Artificial Intelligence in Radiation Oncology: Training the Next Generation.
Pract Radiat Oncol
2021
34478497
pepsickle rapidly and accurately predicts proteasomal cleavage sites for improved neoantigen identification.
Bioinformatics
2021
33937763
Human methylome variation across Infinium 450K data on the Gene Expression Omnibus.
NAR Genom Bioinform
2021
33937530
Radiomic biomarkers of tumor immune biology and immunotherapy response.
Clin Transl Radiat Oncol
2021
34137029
Thromboembolic risk in patients with lung cancer receiving systemic therapy.
Br J Haematol
2021
31424527
neoepiscope improves neoepitope prediction with multivariant phasing.
Bioinformatics
2020
33986221
Utility of the Current Procedural Terminology Codes for Prophylactic Stabilization for Defining Metastatic Femur Disease.
J Am Acad Orthop Surg Glob Res Rev
2020
34316681
Putatively cancer-specific exon-exon junctions are shared across patients and present in developmental and other non-cancer cells.
NAR Cancer
2020
31836083
In Regard to Wallner et al.
Int J Radiat Oncol Biol Phys
2020
32036673
Real-world applications of deep convolutional neural networks in diagnostic cancer imaging.
Chin Clin Oncol
2020
32890543
Meeting the Challenge of Scientific Dissemination in the Era of COVID-19: Toward a Modular Approach to Knowledge-Sharing for Radiation Oncology.
Int J Radiat Oncol Biol Phys
2020
32616555
A phase II single-arm study of pembrolizumab with enzalutamide in men with metastatic castration-resistant prostate cancer progressing on enzalutamide alone.
J Immunother Cancer
2020
32303592
Human Leukocyte Antigen Susceptibility Map for Severe Acute Respiratory Syndrome Coronavirus 2.
J Virol
2020
32228719
Burden of tumor mutations, neoepitopes, and other variants are weak predictors of cancer immunotherapy response and overall survival.
Genome Med
2020
30817170
Career Enrichment Opportunities at the Scientific Frontier in Radiation Oncology.
JCO Clin Cancer Inform
2019
31647502
Tumor Mutation Burden-From Doubts to Concerns.
JAMA Oncol
2019
31668208
Artificial Intelligence in Radiation Oncology.
Hematol Oncol Clin North Am
2019
31238022
Clinical Documentation and Patient Care Using Artificial Intelligence in Radiation Oncology.
J Am Coll Radiol
2019
31492404
Using Artificial Intelligence to Improve the Quality and Safety of Radiation Therapy.
J Am Coll Radiol
2019
31128144
Enhancing Career Paths for Tomorrow's Radiation Oncologists.
Int J Radiat Oncol Biol Phys
2019
30998812
The Potential and Pitfalls of Crowdsourced Algorithm Development in Radiation Oncology.
JAMA Oncol
2019
28964588
Precision Oncology and Genomically Guided Radiation Therapy: A Report From the American Society for Radiation Oncology/American Association of Physicists in Medicine/National Cancer Institute Precision Medicine Conference.
Int J Radiat Oncol Biol Phys
2018
31773030
Quality of Life of Postoperative Photon versus Proton Radiation Therapy for Oropharynx Cancer.
Int J Part Ther
2018
33458411
Stereotactic body proton therapy for liver tumors: Dosimetric advantages and their radiobiological and clinical implications.
Phys Imaging Radiat Oncol
2018
30191856
The Future of Artificial Intelligence in Radiation Oncology.
Int J Radiat Oncol Biol Phys
2018
29907338
Artificial intelligence in radiation oncology: A specialty-wide disruptive transformation?
Radiother Oncol
2018
30353870
Artificial Intelligence in Radiation Oncology Imaging.
Int J Radiat Oncol Biol Phys
2018
29653567
Population-level distribution and putative immunogenicity of cancer neoepitopes.
BMC Cancer
2018
25812046
Development and evaluation of a standardized method and atlas for contouring primary and permanent dentition.
Dentomaxillofac Radiol
2015
26581156
A Resident's Perspective on Global Health Rotations in Radiation Oncology.
Int J Radiat Oncol Biol Phys
2015
25734796
Pencil-beam scanning proton therapy for anal cancer: a dosimetric comparison with intensity-modulated radiotherapy.
Acta Oncol
2015
24272358
Radiotherapy and the tumor microenvironment: mutual influence and clinical implications.
Adv Exp Med Biol
2014
25086521
A dosimetric comparison of proton and photon therapy in unresectable cancers of the head of pancreas.
Med Phys
2014
23332385
Dose to the developing dentition during therapeutic irradiation: organ at risk determination and clinical implications.
Int J Radiat Oncol Biol Phys
2013
22079941
Maternal gametic transmission of translocations or inversions of human chromosome 11p15.5 results in regional DNA hypermethylation and downregulation of CDKN1C expression.
Genomics
2012
22543209
Hypofractionated whole-breast radiation therapy: does breast size matter?
Int J Radiat Oncol Biol Phys
2012
21373886
DNA methylation changes in murine breast adenocarcinomas allow the identification of candidate genes for human breast carcinogenesis.
Mamm Genome
2011
21957152
Late-replicating heterochromatin is characterized by decreased cytosine methylation in the human genome.
Genome Res
2011
20060885
Experimental approaches to the study of epigenomic dysregulation in ageing.
Exp Gerontol
2010
20497131
Tissue-specific dysregulation of DNA methylation in aging.
Aging Cell
2010
20194508
Experimental intrauterine growth restriction induces alterations in DNA methylation and gene expression in pancreatic islets of rats.
J Biol Chem
2010
20126273
Cytosine methylation dysregulation in neonates following intrauterine growth restriction.
PLoS One
2010
20136551
Epigenetic basis for fetal origins of age-related disease.
J Womens Health (Larchmt)
2010
1 - 50 of 61
Column Actions
Search
Recommended Authors
David C Qian
Winship Cancer Institute of Emory University
Career Start Year
2015
Number of shared co-authors
0
Jennifer Y Y Kwan
Princess Margaret Cancer Centre, University of Toronto
Career Start Year
2013
Number of shared co-authors
1
Christine B Peterson
University of Texas MD Anderson Cancer Center
Career Start Year
2013
Number of shared co-authors
2
Chen Hu
Johns Hopkins University School of Medicine
Career Start Year
2009
Number of shared co-authors
3
Pankaj Vats
Michigan Center for Translational Pathology, University of Michigan ann arbor
Career Start Year
2008
Number of shared co-authors
1
Ritu Roy
University of California San Francisco.
Career Start Year
2007
Number of shared co-authors
0
Jochen K Lennerz
Massachusetts General Hospital/Harvard Medical School
Career Start Year
2004
Number of shared co-authors
0
Daniel S Higginson
Memorial Sloan Kettering Cancer Center
Career Start Year
2003
Number of shared co-authors
1
Olivier Elemento
Meyer Cancer Center
Career Start Year
2002
Number of shared co-authors
6
Michael Slifker
Fox Chase Cancer Center
Career Start Year
2002
Number of shared co-authors
0
Keyue Ding
Queen's University
Career Start Year
2002
Number of shared co-authors
1
Frederick Klauschen
Institute of Pathology, Ludwig-Maximilians-Universitat Munchen
Career Start Year
2002
Number of shared co-authors
0
Syed Haider
Institute of Cancer Research
Career Start Year
2002
Number of shared co-authors
1
Pingfu Fu
Case Western Reserve University
Career Start Year
2000
Number of shared co-authors
1
Jeffrey S Morris
Perelman School of Medicine, University of Pennsylvania
Career Start Year
1999
Number of shared co-authors
1
Kerby Shedden
University of Michigan ann arbor
Career Start Year
1999
Number of shared co-authors
0
Samuel L Volchenboum
University of Chicago
Career Start Year
1998
Number of shared co-authors
0
Francesca M Buffa
University of Oxford
Career Start Year
1998
Number of shared co-authors
1
Xingzhi Song
The University of Texas MD Anderson Cancer Center
Career Start Year
1998
Number of shared co-authors
0
Elizabeth Garrett-Mayer
Center for Research and Analytics, American Society of Clinical Oncology
Career Start Year
1997
Number of shared co-authors
2
Jorge Nieva
Norris Comprehensive Cancer Center, University of Southern California
Career Start Year
1995
Number of shared co-authors
0
Stanley K Liu
Odette Cancer Centre, University of Toronto
Career Start Year
1995
Number of shared co-authors
2
Adam B Olshen
12224University of California san francisco
Career Start Year
1993
Number of shared co-authors
1
Kathleen E Houlahan
University of California los angeles
Career Start Year
1991
Number of shared co-authors
3
Wei Xu
Princess Margaret Cancer Centre
Career Start Year
1991
Number of shared co-authors
2
Luigi Marchionni
Weill-Cornell School of Medicine
Career Start Year
1989
Number of shared co-authors
0
Mark Lawler
Queens University Belfast Belfast
Career Start Year
1988
Number of shared co-authors
3
David M Berman
Queen's University
Career Start Year
1982
Number of shared co-authors
1
Paul C Boutros
University of California los angeles
Career Start Year
1970
Number of shared co-authors
15
Francesca Demichelis
University of Trento
Career Start Year
1969
Number of shared co-authors
4
row(s) 1 - 30 of 30
Collaborators
John M Greally
Co-authored papers
14
Clifton D Fuller
The University of Texas MD Anderson Cancer Center
Co-authored papers
11
Mary A Wood
Phase Genomics Inc.
Co-authored papers
10
Abhinav Nellore
Oregon Health & Science University
Co-authored papers
10
Charles R Thomas
Oregon Health & Science University
Co-authored papers
8
Masako Suzuki
Co-authored papers
6
Sean K Maden
Oregon Health & Science University
Co-authored papers
5
Nir Barzilai
Co-authored papers
4
Ari Melnick
Co-authored papers
4
Roland D Green
NimbleGen Systems Inc.
Co-authored papers
3
Hugo J W L Aerts
Harvard Medical School
Co-authored papers
3
Todd A Richmond
Co-authored papers
3
Kyle Ellrott
Oregon Health & Science University
Co-authored papers
3
Seth A Rosenthal
Sutter Cancer Centers Radiation Oncology Services
Co-authored papers
3
Curtiland Deville
Johns Hopkins University
Co-authored papers
3
Adam J Struck
Oregon Health & Science University
Co-authored papers
2
Kasper D Hansen
Johns Hopkins University School of Medicine
Co-authored papers
2
Mark Reimers
Institute for Quantitative Health Science and Engineering, Michigan State University
Co-authored papers
2
George V Thomas
Knight Cancer Institute, Oregon Health and Science University
Co-authored papers
2
Hesham Elhalawani
Co-authored papers
2
Joanne B Weidhaas
University of California-Los Angeles
Co-authored papers
2
Eric E Bouhassira
Albert Einstein College of Medicine
Co-authored papers
2
Gil Atzmon
Co-authored papers
2
Austin Nguyen
Oregon Health & Science University
Co-authored papers
1
Jeremy A Squire
University of Sao Paulo
Co-authored papers
1
Margaret A Tucker
National Cancer Institute
Co-authored papers
1
Syed A Hussain
University of Sheffield and Sheffield Teaching Hospitals
Co-authored papers
1
Neha Vapiwala
Abramson Cancer Center, University of Pennsylvania
Co-authored papers
1
Alireza Fotouhi Ghiam
University of British Columbia
Co-authored papers
1
Archana Sehrawat
Knight Cancer Institute and.
Co-authored papers
1
1 - 30